CompletedNCT03573297
Official study titleA Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in a Dose-reduction Paradigm in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States, Bulgaria, Malaysia, + 7 others
- Sponsor
- AbbVie
CompletedNCT04407767
Official study titlePersonalizing Cognitive Processing Therapy With a Case Formulation Approach to Intentionally Target Impairment in Psychosocial Functioning Associated With PTSD
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixPTSDBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
Active Not RecruitingACTRN12617000494336
Official study titleA Case Series Evaluation of a Pilot Brief Behavioural Activation Intervention for Pathological Grief
This study is no longer accepting new participants.
In AustraliaProlonged grief disorder, PTSD, ...Interventional studyAges 18+
- Countries
- Australia
- Sponsor
- Curtin University
CompletedACTRN12610000229077
Official study titleA case series evaluation of the Maudsley Model for Treatment of Adults with Anorexia nervosa (MANTRA) using body mass index and global Eating Disorder Examination as indicators of good outcome
This study has finished and is no longer accepting participants.
Location not clearly listedEating disordersObservational studyAges 16+
- Countries
- Sponsor
- Flinders University
CompletedACTRN12623001086651
Official study titleA multiple baseline case series evaluating the effects of imagery rescripting on symptoms of generalised anxiety disorder
This study has finished and is no longer accepting participants.
In AustraliaAnxietyInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- UNSW Sydney
CompletedNCT04708262
This study has finished and is no longer accepting participants.
In ManchesterSuicidalityInterventional studyAges 13–17
- Countries
- United Kingdom
- Sponsor
- University of Manchester
CompletedNCT06845878
Official study titleA Conversational Agent To Support Follow-up Care For Individuals In Recovery For Substance Use Disorder
This study has finished and is no longer accepting participants.
In BostonAddictionInterventional studyAges 18–65
- Countries
- United States
- Sponsor
- Dimagi Inc.
CompletedNCT06446089
Official study titleThe Feasibility of a Culturally Tailored Mobile App-based Thinking Healthy Program for Mental Health Support of East Asian Pregnant Immigrants in Canada
This study has finished and is no longer accepting participants.
In KingstonDepressionBehavioural studyAges 18+
- Countries
- Canada
- Sponsor
- Shahirose Sadrudin Premji
CompletedNCT00500149
Official study titleA Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Shire
CompletedNCT00149812
Official study titleA Clinic-based Program for Families of Depressed Mothers
This study has finished and is no longer accepting participants.
In BaltimoreDepressionBehavioural studyAges 8+
- Countries
- United States
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
CompletedNCT02697643
This study has finished and is no longer accepting participants.
In WalthamAddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Inflexxion, Inc.
CompletedNCT00566020
Official study titleStudy SCA106052, a Clinical Evaluation of BW430C (Lamotrigine) in Bipolar I Disorder- Long-term Extension Study (Extension of Study SCA104779 (NCT00550407))
This study has finished and is no longer accepting participants.
Multiple locations, including AichiBipolarityMedication studyAges 20+
- Countries
- Japan
- Sponsor
- GlaxoSmithKline